Form 4: Lexeo Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations

Jenny Robertson, Chief Legal Officer of Lexeo Therapeutics, sold 521 shares of common stock on May 16, 2025, to cover tax obligations related to the release of restricted stock units.

Summary

• On May 16, 2025, Jenny Robertson, the Chief Legal Officer of Lexeo Therapeutics, sold 521 shares of the company's common stock.
• The sale was executed at a price of $2.774 per share.
• This transaction was conducted to cover tax obligations arising from the release of restricted stock units (RSUs).
• Following the transaction, Robertson still beneficially owns 63,098 shares, which includes 52,577 restricted stock units.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Sales of shares by company officers are a routine part of corporate governance, often related to compensation and tax planning. It's common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved and the stated reason for the sale.

Key Dates

Keywords

Lexeo Therapeutics, Jenny Robertson, Chief Legal Officer, Form 4, Stock Sale, Restricted Stock Units, LXEO, Tax Obligations